SMAP-29 is a cathelicidin-derived peptide deduced from sheep myeloid mRNA,
The C-terminally amidated form of this peptide was chemically synthesized a
nd shown to exert a potent antimicrobial activity. Antibiotic-resistant cli
nical isolates highly susceptible to this peptide include MRSA and VREF iso
lates, that are a major worldwide problem, and mucoid Pseudomonas aeruginos
a associated with chronic respiratory inflammation in CF patients. In addit
ion, SMAP-29 is also active against fungi, including Cryptococcus neoforman
s isolated from immunocompromised patients. SMAP-29 causes significant morp
hological alterations of the bacterial surfaces, as shown by scanning elect
ron microscopy, and is also hemolytic against human, but not sheep erythroc
ytes. Its potent antimicrobial activity suggests that this peptide is an ex
cellent candidate as a lead compound for the development of novel antiinfec
tive agents. (C) 1999 Federation of European Biochemical Societies.